Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.
Einband grossRadiotheranostics - A Primer for Medical Physicists I
ISBN/GTIN

Radiotheranostics - A Primer for Medical Physicists I

E-BookEPUB0 - No protectionE-Book
216 Seiten
Englisch
Taylor & Franciserschienen am20.02.20241. Auflage
This book covers scientific, clinical, and educational aspects of radiotheranostics in cancer control. Setting the framework, the first volume defines radiotheranostics and describes the history of radionuclide therapy and theranostics, and the biology of cancer.mehr
Verfügbare Formate
BuchGebunden
EUR232,50
E-BookEPUB0 - No protectionE-Book
EUR237,99
E-BookPDF0 - No protectionE-Book
EUR237,99

Produkt

KlappentextThis book covers scientific, clinical, and educational aspects of radiotheranostics in cancer control. Setting the framework, the first volume defines radiotheranostics and describes the history of radionuclide therapy and theranostics, and the biology of cancer.
Details
Weitere ISBN/GTIN9781003836100
ProduktartE-Book
EinbandartE-Book
FormatEPUB
Format Hinweis0 - No protection
FormatE101
Erscheinungsjahr2024
Erscheinungsdatum20.02.2024
Auflage1. Auflage
Seiten216 Seiten
SpracheEnglisch
Dateigrösse4653 Kbytes
Illustrationen14 schwarz-weiße und 20 farbige Abbildungen, 10 schwarz-weiße und 10 farbige Fotos, 4 schwarz-weiße und 10 farbige Zeichnungen, 17 schwarz-weiße Tabellen
Artikel-Nr.12253443
Rubriken
Genre9200

Inhalt/Kritik

Inhaltsverzeichnis
Section I: Introduction. Chapter 1: What is radiotheranostics? Chapter 2: History of radionuclide therapy and theranostics. Chapter 3: Biological principles behind targeted radionuclide therapy for cancer. Section II: Clinical Applications of Targeted Radionuclide Therapy in Cancer Control. Chapter 4: Unconjugated radionuclides. Chapter 5: Radionuclide-conjugated cancer-specific vectors: Peptides. Chapter 6: Radionuclide-conjugated cancer-specific vectors: Small Molecules and antibodies. Chapter 7: Radionuclide-conjugated cancer-specific vectors: Nanoparticles. Chapter 8: Introduction to clinical trials and drug development for radionuclide therapies. Chapter 9: Epidemiologic Studies of Cancer Risk among Patients Administered Radionuclides. Chapter 10: Adverse effects of radionuclide therapy. Section III: Radiation Chemistry and Physics. Chapter 11: Radionuclide production. Chapter 12: Radioactivity measurement and traceability. Chapter 13: Instrumentation, calibration, quantitative imaging, and quality control. Section IV: The Future. Chapter 14: Human resources: Multidisciplinary team education, training, and competence. Chapter 15: Theranostics today: Looking backwards to tomorrow.mehr

Autor

Cari (Caridad) Borrás is a certified medical physicist in Washington, DC, USA, where she works as an international consultant and has an adjunct faculty position at the George Washington University School of Medicine and Health Sciences. She obtained a Doctor of Science (Physics) degree from the University of Barcelona, Spain, having done a thesis research project on the dosimetry and embryological effects of Astatine- 211 at Thomas Jefferson University in Philadelphia, PA, USA, as a Fulbright scholar. She has lectured in more than 300 seminars/courses/congresses, many organized by her; authored/contributed around 100 articles and six book chapters and edited two books. She is a Fellow of ACR, AAPM, IOMP, HPS, and IUPESM, and has received awards/recognitions from SEFM, AAPM, IOMP, ALFIM, ACCE, ACR, and ABR.

Michael G. Stabin is a Certified Health Physicist, President of the Radiation Dose Assessment Resource, Inc., living in Kennewick, WA, USA, where he worked for NV5 - Technical Engineering & Consulting Solutions and Hanford Mission Integration Solutions. He was an Associate Professor in the Radiology and Radiological Sciences Department at Vanderbilt University, in Nashville, TN, and a Scientist at the Radiation Internal Dose Information Center of Oak Ridge Institute for Science and Education. He received a Ph.D. in Nuclear Engineering (Health Physics emphasis) from the University of Tennessee, is a member of the HPS and the SNMMI, and is also a Fulbright scholar. He has over 225 publications in the open literature, most on internal dosimetry for nuclear medicine applications, including complete textbooks on health physics and internal dose assessment.